Explainer Episode 65 – Reviewing Michael Cannon’s Book “Recovery”

In this RTP explainer episode 65, we are joined by Michael Cannon, Director of Health Policy Studies at the Cato Institute, and Christina Sandefur, Executive Vice President of the Goldwater Institute to discuss Michael Cannon’s new book, Recovery. 

Listen in as these experts consider the role of government agencies like the FDA in health spaces across America. “Recovery” discusses treatments approved by the FDA and the implications of approved drugs entering the market. Americans are inadvertently affected by the decisions of government agencies.

“Recovery” argues the FDA takes away people’s rights to make their own health decisions. Does the FDA prohibit safe and effective drugs from entering the market? In this episode, experts discuss the implications of the decisions made by the FDA and the consequences of unsafe access to drugs.

Copies of Michael Cannon’s book can be found at, https://www.cato.org/books/recovery

Michael F. Cannon

Director of Health Policy Studies

Cato Institute

Christina Sandefur

Executive Vice President

Goldwater Institute

FDA & Health

The Federalist Society and Regulatory Transparency Project take no position on particular legal or public policy matters. All expressions of opinion are those of the speaker(s). To join the debate, please email us at [email protected].

Related Content

Skip to content